Evaluation of the ReNu Amniotic Suspension Allograft After Marrow Stimulation in the Treatment of Osteochondral Defects

Trial Profile

Evaluation of the ReNu Amniotic Suspension Allograft After Marrow Stimulation in the Treatment of Osteochondral Defects

Recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Apr 2018

At a glance

  • Drugs Amniotic cell therapy-NuCel (Primary)
  • Indications Bone disorders
  • Focus Therapeutic Use
  • Sponsors Nutech Medical
  • Most Recent Events

    • 02 Apr 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Oct 2019.
    • 08 Jun 2017 Planned End Date changed from 1 Jun 2019 to 1 Oct 2019.
    • 08 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top